Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Standard BioTools: Outlook Still Murky [Seeking Alpha]
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses [Yahoo! Finance]
Standard BioTools (NASDAQ:LAB) was upgraded by analysts at Zacks Research to a "hold" rating.